FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Hospira Ondansetron Injection Recall

Ondansetron Injection, USP, 4mg/2mL, (2mg/ml), 2mL single-dose Fliptop Vial, Rx only, S…

Hospira, Inc. · Lake Forest, IL

Risk level
Class II
Reported by FDA
Aug 14, 2013
Recall ID
D-851-2013
Check your lot numberHow we source this data

Summary

Hospira recalled Ondansetron Injection starting May 20, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-851-2013 on Aug 14, 2013. Reason: Presence of Particulate; lot being recalled as a precaution due to the discovery of 2 particles found in a lot which preceded the recalled lot. Status: Terminated.

Why it was recalled

Presence of Particulate; lot being recalled as a precaution due to the discovery of 2 particles found in a lot which preceded the recalled lot

Product description

Ondansetron Injection, USP, 4mg/2mL, (2mg/ml), 2mL single-dose Fliptop Vial, Rx only, Sterile, NDC 0409-4755-03, Hospira, Inc, Lake Forest, IL 60045.

Lot numbers, UPCs & expiration codes

Lot 25394DK, exp. 01/2015

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-851-2013
Classification
Class II
Status
Terminated
Recall initiated
May 20, 2013
FDA report date
Aug 14, 2013
Quantity
340,600 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Hospira, Inc.

Original FDA data

Every field from FDA enforcement report D-851-2013, exactly as published.

Show all FDA fields
City
Lake Forest
State
IL
Status
Terminated
Country
United States
Event ID
65300
Address
600 N Field Dr Bldg J45
Code information
Lot 25394DK, exp. 01/2015
Postal code
60045
Report date
Aug 14, 2013
Product type
Drugs
Recall number
D-851-2013
Classification
Class II
Recalling firm
Hospira, Inc.
Product quantity
340,600 vials
Termination date
Oct 28, 2014
Reason for recall
Presence of Particulate; lot being recalled as a precaution due to the discovery of 2 particles found in a lot which preceded the recalled lot
Voluntary / mandated
Voluntary: Firm initiated
Product description
Ondansetron Injection, USP, 4mg/2mL, (2mg/ml), 2mL single-dose Fliptop Vial, Rx only, Sterile, NDC 0409-4755-03, Hospira, Inc, Lake Forest, IL 60045.
Distribution pattern
Nationwide
Recall initiation date
May 20, 2013
Initial firm notification
Letter
Center classification date
Aug 7, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-851-2013, published Aug 14, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls